Grant: Master's Award: Canada Graduate Scholarships
University of Victoria (British Columbia)
$17,500.00
Identification of earlier biomarkers for Alzheimer's disease: A neuroimaging study of individuals with subjective cognitive decline
EF 2017-18
Résumé
Alzheimer's disease (AD) is a degenerative neurocognitive disorder for which there is currently no cure. As we age, most people experience some decline in memory and other thinking skills. These age related changes are well known and understood as a normal part of the aging process. However, some individuals experience Subjective Cognitive Decline (SCD), which occurs when individuals report a decline that they perceive to be greater than expected with normal aging. These individuals with SCD, represent a group at early risk of AD. Although individuals with SCD do not differ from healthy individuals on pen and paper cognitive tests, it is unknown whether their brains look different or are working differently. The proposed study will use brain imaging to examine differences in brain structure and function in individuals with SCD and healthy individuals, which may help identify early changes associated with AD. Earlier detection of AD would allow preventative measures to be put into place as soon as possible, reducing the devastating effects of AD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
British Columbia, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
386629
Name
Parker Ashleigh F
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Identification of earlier biomarkers for Alzheimer's disease: A neuroimaging study of individuals with subjective cognitive decline
Programtype2
Studentship Programs
Orgnameinp2
University of Victoria (British Columbia)
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Alzheimer'S Disease; Default Mode Network; Functional Magnetic Resonance Imaging (Fmri); Magnetic Resonance Imaging (Mri); Neuroimaging; Resting State Networks; Subjective Cognitive Decline
Abstract
Alzheimer's disease (AD) is a degenerative neurocognitive disorder for which there is currently no cure. As we age, most people experience some decline in memory and other thinking skills. These age related changes are well known and understood as a normal part of the aging process. However, some individuals experience Subjective Cognitive Decline (SCD), which occurs when individuals report a decline that they perceive to be greater than expected with normal aging. These individuals with SCD, represent a group at early risk of AD. Although individuals with SCD do not differ from healthy individuals on pen and paper cognitive tests, it is unknown whether their brains look different or are working differently. The proposed study will use brain imaging to examine differences in brain structure and function in individuals with SCD and healthy individuals, which may help identify early changes associated with AD. Earlier detection of AD would allow preventative measures to be put into place as soon as possible, reducing the devastating effects of AD.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Parker, Ashleigh F
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~
